S. Korean Actor Yoo Ah-in Jailed for One Year for Drugs

Yoo Ah-in arrives at the Seoul Central District Court in Seoul, South Korea, September 3, 2024. (Yonhap via Reuters)
Yoo Ah-in arrives at the Seoul Central District Court in Seoul, South Korea, September 3, 2024. (Yonhap via Reuters)
TT

S. Korean Actor Yoo Ah-in Jailed for One Year for Drugs

Yoo Ah-in arrives at the Seoul Central District Court in Seoul, South Korea, September 3, 2024. (Yonhap via Reuters)
Yoo Ah-in arrives at the Seoul Central District Court in Seoul, South Korea, September 3, 2024. (Yonhap via Reuters)

High-profile South Korean actor Yoo Ah-in was found guilty Tuesday of illegal use of the anesthetic drug propofol and handed a one-year jail term, the Yonhap news agency reported.

Yoo, whose real name is Uhm Hong-sik, was accused of using propofol on 181 occasions between 2020 and 2022. The drugs were administered at professional clinics, under the guise of having cosmetic procedures done.

The prosecution had sought a four-year sentence for the "Hellbound" actor, but the Seoul Central District Court handed the 37-year-old a one-year jail term, Yonhap reported.

"He is deemed guilty of all his purchases for habitual drug use," the court stated in its ruling, according to Yonhap News TV.

The court said Yoo had committed the offences "in disregard of relevant regulations" and displayed a "lack of caution against drug substances".

A doctor who administered propofol to Yoo without a proper prescription was fined 40 million won ($30,000) last month.

Propofol, while primarily used as a surgical anesthetic, is sometimes abused recreationally, often with the involvement of medical professionals who may be willing to provide it without a legitimate clinical need.

An overdose of the drug was cited as the cause of pop star Michael Jackson's death in 2009.

"I am sorry for having caused concern to many people," Yoo was quoted as saying in court by Yonhap.

Yoo rose to stardom in the South following his debut in 2003, starring in a range of television dramas and films across genres, and becoming one of the country's most recognizable actors.

This trial marks the latest drug scandal to hit South Korea.

In a similar incident, K-pop star G-Dragon faced allegations of drug use and was questioned by police, but the case was dropped in November due to insufficient evidence.

Actor Lee Sun-kyun, known for his role in the Oscar-winning film "Parasite", took his own life in December after being accused of illegal substance use, sparking public outrage over what many perceived as an excessive investigation by the police without substantial evidence.

Lee Jae-yong, then vice-chairman of Samsung Electronics, was convicted in 2021 of illegally using propofol and was fined 70 million won. He was found guilty of repeatedly receiving the anesthetic at a plastic surgery clinic in Seoul on numerous occasions over several years.



Netflix Subscriber Additions Likely Slowed, Growth Strategy in Focus

FILE PHOTO: The Netflix logo is shown on one of their Hollywood buildings in Los Angeles, California, US, July 12, 2023. REUTERS/Mike Blake/File Photo
FILE PHOTO: The Netflix logo is shown on one of their Hollywood buildings in Los Angeles, California, US, July 12, 2023. REUTERS/Mike Blake/File Photo
TT

Netflix Subscriber Additions Likely Slowed, Growth Strategy in Focus

FILE PHOTO: The Netflix logo is shown on one of their Hollywood buildings in Los Angeles, California, US, July 12, 2023. REUTERS/Mike Blake/File Photo
FILE PHOTO: The Netflix logo is shown on one of their Hollywood buildings in Los Angeles, California, US, July 12, 2023. REUTERS/Mike Blake/File Photo

Netflix could report its slowest subscriber additions in six quarters on Thursday as gains from a password-sharing crackdown ease, with investors looking for signs its nascent ad revenue business is accelerating.
The streaming giant likely added 4 million subscribers in the July-September period, according to analysts' estimates compiled by LSEG. Netflix originals such as "The Accident" and "The Perfect Couple" were among the top streamed titles in the US during the quarter, Nielsen data showed, according to Reuters.
As the pace of sign-ups slows, Netflix is trying to shift investor attention towards other performance measures including revenue growth and margins. It will stop reporting subscriber data from 2025.
"Their focus is to continue to grow subscribers at a healthy clip while also leveraging their scale, ability to raise prices and increase advertising dollars," said Pivotal Research analyst Jeff Wlodarczak.
The company's ad-supported plan has been growing but Netflix does not offer details on the tier's financial performance and does not expect it to become a primary driver of growth until 2026.
This has raised some concerns about its growth trajectory.
"They're making less than a billion dollars a year in the US on advertising, saying that doesn't make them look good," eMarketer television and streaming analyst Ross Benes said.
Some analysts have said the company needs to raise prices and phase out more of its ad free plans to nudge customers towards the tier with commercials as it usually brings in more revenue per user.
The company said in July last year it would stop offering the $9.99 a month basic plan without commercials to new users in the US and the UK, and phase it out for existing subscribers.
Netflix charges $6.99 per month in the US for the ad tier, while its standard plan without commercials is priced at $15.49 a month.
It has not raised the price of its standard plan since early 2022, while its ad-supported tier has been priced the same since its launch in late 2022.
The company, which operates in more than 190 countries, is expected to report ad revenue of $242.7 million in the third quarter, according to the average of estimates from three analysts compiled by LSEG. Overall revenue is expected to grow 14.3%, a slightly slower pace than the previous three months, to $9.76 billion.
To attract more advertisers, the streamer is focusing on live events including sports. Netflix will air the highly anticipated Jake Paul vs. Mike Tyson boxing fight in November, followed by its first NFL games in December.
The second season of hit South Korean drama series "Squid Game,” expected to release in December, could help the company draw subscribers in the last quarter of the year.
Netflix stock has risen 12.4% since it reported second-quarter results in July, compared with a 5% rise in the S&P 500 index.